Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

TARO-DEFERASIROX Tablets
« Back to list view

Product Information

  • DIN:
    02507315
  • Active Ingredients :
    Deferasirox
  • Innovator Name:
    JADENU®
  • Category:
    Iron chelating agent
  • Dosage form:
    Film coated tablets
  • Strength:
    90 mg
  • Route of Administration:
    Oral
  • Colour:
    light blue
  • Shape:
    oval
  • Markings:
    debossed with ‘S102’ on one side and plain on the other side
  • Package size:
    30 Bottles
  • UPC Code:
    063691100541
  • Non-medicinal ingredients :
    Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, poloxamer (188), povidone (K30); film-coating material: FD&C blue #2/Indigo carmine aluminum lake, hypromellose, polyethylene glycol (4000), talc, titanium dioxide.
TARO-DEFERASIROX Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507323
  • Active Ingredients :
    Deferasirox
  • Innovator Name:
    JADENU®
  • Category:
    Iron chelating agent
  • Dosage form:
    Film coated tablets
  • Strength:
    180 mg
  • Route of Administration:
    Oral
  • Colour:
    medium blue
  • Shape:
    oval
  • Markings:
    debossed with ‘S103’ on one side and plain on the other side
  • Package size:
    30 Bottles
  • UPC Code:
    063691100558
  • Non-medicinal ingredients :
    Dioxyde de silice colloïdale, crospovidone, stéarate de magnésium, cellulose microcristalline, poloxamère (188), povidone (K30); composition de la pellicule : bleu no 2 de FD&C/laque d’aluminium carmin d’indigo, hypromellose, polyéthylèneglycol (4000), talc, dioxyde de titane.
TARO-DEFERASIROX Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507331
  • Active Ingredients :
    Deferasirox
  • Innovator Name:
    JADENU®
  • Category:
    Iron chelating agent
  • Dosage form:
    Film coated tablets
  • Strength:
    360 mg
  • Route of Administration:
    Oral
  • Colour:
    dark blue
  • Shape:
    oval
  • Markings:
    debossed with ‘S104’ on one side and plain on the other side.
  • Package size:
    30 Bottles
  • UPC Code:
    063691100565
  • Non-medicinal ingredients :
    Colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, poloxamer (188), povidone (K30); film-coating material: FD&C blue #2/Indigo carmine aluminum lake, hypromellose, polyethylene glycol (4000), talc, titanium dioxide.
TARO-DEFERASIROX Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement